Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00320190
Status:
TERMINATED
Last Update Posted:
2013-10-30
First Post:
2006-05-01
Brief Title:
Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia Myeloid Chronic |
Keywords:
| Name | View |
|---|---|
| Chronic phase CML with a suboptimal response after treatment with imatinib | View |